ALLEGAN, MI (WHTC) - The bottom line remains written in black ink at Perrigo, as second quarter earnings released today showed sales up 17 percent to 838 million dollars, and income improving 14 percent to 112 million, or $1.20 per share. Chairman/CEO Joe Papa says he’s “excited about our future” and that the teams from Allegan-based generic drug maker are “executing on their plans, which are the foundation for sustaining our growth.”
